Jazz Pharmaceuticals

122.99
-3.41 (-2.70%)
At close: Mar 28, 2025, 3:59 PM
125.00
1.63%
After-hours: Mar 28, 2025, 05:42 PM EDT

Jazz Pharmaceuticals Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04
Revenue 4.07B 3.83B 3.66B 3.09B 2.36B 2.16B 1.89B 1.62B 1.49B 1.32B 1.17B 872.42M 585.98M 272.28M 173.78M 128.45M 67.51M 65.3M 44.86M 21.44M n/a
Cost of Revenue n/a 435.58M 540.52M 440.76M 148.92M 127.93M 121.54M 110.19M 105.39M 102.53M 117.42M 102.15M 78.42M 13.94M 13.56M 9.64M 13.92M 8.9M 6.97M 4.29M n/a
Gross Profit 4.07B 3.4B 3.12B 2.65B 2.21B 2.03B 1.77B 1.51B 1.38B 1.22B 1.06B 770.28M 507.55M 258.33M 160.22M 118.81M 53.59M 56.4M 37.89M 17.15M n/a
Operating Income 716.63M 578.58M 512.27M 170.28M 765.46M 532.37M 614.84M 528.84M 591.65M 508.22M 195.59M 340.31M 197.84M 127.83M 57.79M 15.93M -170.37M -138.78M -78.05M -78.44M -24.8M
Interest Income n/a n/a 11.5M 1.8M 99.71M 20.5M n/a n/a n/a n/a n/a n/a n/a 75K 6K 34K 1.83M n/a n/a n/a n/a
Pretax Income 470.35M 297.93M -372.78M -112.84M 275.1M 454.3M 529.46M 441.12M 532.45M 435.93M 151.56M 307.95M 177.35M 124.98M 32.78M -6.84M -184.34M -138.83M -47.57M -100.64M n/a
Net Income 560.12M 414.83M -214.14M -328.95M 238.62M 523.37M 447.1M 487.85M 396.83M 329.54M 58.39M 216.31M 288.59M 124.98M 32.78M -6.84M -184.34M -138.83M -59.39M -85.16M -24.8M
Selling & General & Admin 1.39B 1.34B 1.42B 1.45B 854.23M 736.94M 683.53M 544.16M 502.89M 449.12M 406.11M 304.3M 223.88M 108.94M 69M 58.65M 111.4M 78.54M 51.38M 23.55M n/a
Research & Development 445.71M 849.66M 590.45M 505.75M 335.38M 299.73M 226.62M 198.44M 162.3M 135.25M 85.18M 46.62M 20.48M 14.12M 25.61M 36.56M 69.96M 69.79M 54.96M 45.78M n/a
Other Expenses 1.52B 627.28M 599.17M 525.77M 259.58M 354.81M 201.5M 152.06M 101.99M 98.16M 126.58M 79.04M 65.35M 7.45M 7.83M 7.67M 12.83M 46.85M 9.6M 4.96M -24.8M
Operating Expenses 3.35B 2.82B 2.61B 2.48B 1.45B 1.39B 1.11B 894.66M 767.18M 682.53M 617.88M 429.96M 309.71M 130.5M 102.43M 102.88M 194.19M 195.18M 115.94M 74.29M -24.8M
Interest Expense 238.1M 289.44M 288.24M 278.77M 99.71M 72.26M 77.08M 77.76M 61.94M 56.92M 52.71M 26.92M 16.87M 1.68M 12.73M 22.8M 19.74M n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 25.7M 1M 700K n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 3.35B 3.26B 3.15B 2.92B 1.6B 1.52B 1.23B 1B 872.57M 785.06M 735.3M 532.11M 388.13M 144.45M 115.99M 112.52M 208.12M 204.08M 122.91M 78.59M -24.8M
Income Tax -89.77M -119.91M -158.65M 216.12M 33.52M -73.15M 80.16M -47.74M 135.24M 106.4M 94.23M 91.64M -83.79M 2.85M 25.01M 22.77M 43.74M 48K -18.66M 28.01M 24.8M
Shares Outstanding (Basic) 61.84M 63.29M 62.54M 59.69M 55.71M 56.75M 59.98M 60.02M 60.5M 61.23M 59.75M 58.3M 56.64M 41.5M 36.34M 30.02M 25.65M 13.83M 13.47M 13.47M 13.47M
Shares Outstanding (Diluted) 66.01M 72.07M 62.54M 59.69M 56.52M 57.55M 61.22M 61.32M 61.87M 63.04M 62.61M 61.57M 60.2M 46.8M 39.41M 30.02M 25.65M 13.83M 13.47M 13.47M 13.47M
EPS (Basic) 9.06 6.95 -3.42 -5.51 4.28 9.22 7.45 8.13 6.56 5.38 0.98 3.71 5.09 3.01 0.90 -0.23 -7.19 -10.04 -4.41 -6.32 -1.84
EPS (Diluted) 8.49 6.10 -3.42 -5.51 4.22 9.09 7.30 7.96 6.41 5.23 0.93 3.51 4.79 2.67 0.83 -0.23 -7.19 -10.04 -4.41 -6.32 -1.84
EBITDA 716.63M 1.23B 553.78M 1.03B 649.65M 1.01B 932.66M 779M 753.88M 665.97M 583.7M 454.11M 268.45M 136.91M 54.22M 15.93M -125.58M -128.25M -67.74M -51.7M -24.8M
Depreciation & Amortization n/a 638.7M 629.47M 552.48M 278.25M 370.16M 216.73M 165.15M 113.78M 98.16M 126.58M 82.09M 74.23M 7.83M 7.83M 7.67M 15.03M 10.53M 10.31M 5.44M n/a